Have you ever wanted to find a way to better communicate with your doctor, get the most out of your visits, and maximize your treatment plan?
If yes, please join us this Thursday, June 13, at 7 pm EST for an intimate conversation between neurologist and headache specialist Abby Chua, DO, and patient advocate Katie Golden. Dr. Chua and Katie will discuss what patients and doctors can learn from one another, and offer tips for interacting.
In time for Migraine & Headache Awareness Month, U.S. Pain Foundation has released its third edition of the INvisible Project focusing on headache and migraine diseases. The publication depicts the reality of life with pain, and why people living with headaches diseases need and deserve more help, treatment options, and research. It also serves as an inspiration to those living with the disease, offering hope and resources.
Migraine, headache, and cluster diseases affect more than 38 million Americans. To increase understanding and empathy for those with these disorders, U.S. Pain Foundation and CHAMP (the Coalition For Headache And Migraine Patients) need your help during National Migraine & Headache Awareness Month (#MHAM). The theme this year is #SowingtheSeeds.
MHAM began June 1, so jump in as soon as you can! You can get involved in the following ways:
While National Migraine and Headache Awareness Month (MHAM) wrapped up in June, U.S. Pain Foundation is continuing to raise awareness through its traveling display of the INvisible Project: Migraine second edition. Below is a photo recap of June and the ongoing efforts to bring about change for people living with headache and migraine disease.
It’s National Migraine and Headache Awareness Month (MHAM), and we have a number of exciting developments to kick it off, as well as numerous ways to participate. Be sure to follow U.S. Pain on Facebook and Twitter to stay up to date on the latest news, events, and ways to get involved.
First-ever migraine prevention drug approved
On May 17, the Food and Drug Administration (FDA) approved the first-ever migraine preventive drug. Often referred to as a CGRP (calcitonin gene-related peptide) or CGRP inhibitor, the drug blocks the CGRP receptor that is believed to play a role in migraine.
U.S. Pain Foundation is teaming up with Coalition For Headache And Migraine Patients (CHAMP) for National Migraine & Headache Awareness Month (MHAM) this June. If interested in taking part, please respond quickly to ensure your efforts are completed in June.
Here are three ways you can get involved:
MHAM Proclamation: Submit a request for a ceremonial proclamation from your state or local representatives. We’ll provide the template, instructions and support. Interested? Send an email to email@example.com for more details and please include the state in which you live. Thanks to Ambassador Jeannette Rotondi for her work on this project.
U.S. Pain was pleased to lead or participate in a variety of efforts and activities related to Migraine and Headache Awareness Month in June. Below is a slideshow of highlights from throughout the month.